Cancelled by the investigator Clinical trial for umbilical cord blood CIK and NK cells in the treatment of mild and general patients infected with novel coronavirus pneumonia (COVID-19)

Clinical trial for umbilical cord blood CIK and NK cells in the treatment of mild and general patients infected with novel coronavirus pneumonia (COVID-19)

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000030329

Enrollment

Unknown

Registered

2020-02-28

Start date

2020-03-05

Completion date

Unknown

Last updated

2020-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Control group:conventional therapy

CIK group:Umbilical cord blood CIK cells (1.6×10E8/kg) were injected twice every other day.

NK group:Umbilical cord blood NK cells (1.6×10E8/kg) were injected twice every other day.

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. New-type coronavirus infection is diagnosed as mild or common (diagnosed according to the "Notice on the Issuance of a New Coronavirus-Infected Pneumonia Diagnosis and Treatment Plan (Trial Implementation of the Sixth Edition)") or patients with poor immune function (cured discharged patients but peripheral hemolymph Cell count and classification are abnormal). 2. Aged 18-65 years; 3. Sign informed consent.

Exclusion criteria

Exclusion criteria: Doctors and researchers consider that the patient inappropriate to enroll in the study.

Design outcomes

Primary

Measure	Time frame
Status of immune function;The time of nucleic acid turns to negative;Length of stay in-hospital;	—

Secondary

Measure	Time frame
The incidence rate of complication;	—

Countries

China

Contacts

Public ContactGao Jun

The Second Affiliated Hospital of Xi'an Medical University

13816012151@163.com+86 13816012151

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026